Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
about
Beneficial effects of estrogen in a mouse model of cerebrovascular insufficiencyRisk of Parkinson's disease after tamoxifen treatment.Differences in peripheral sensory input to the olfactory bulb between male and female mice.Female reproductive factors, menopausal hormone use, and Parkinson's disease.17β-estradiol enhances memory duration in the main olfactory bulb in CD-1 mice.Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.Male/Female differences in neuroprotection and neuromodulation of brain dopamineRisk factors for Parkinson's disease may differ in men and women: an exploratory study.Variants in estrogen-related genes and risk of Parkinson's diseaseEstrogen, testosterone, and methamphetamine toxicity.Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.Pregnancy in Parkinson's disease: case report and discussion.A phenotypic model recapitulating the neuropathology of Parkinson's disease.Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice.Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.Tamoxifen and the Risk of Parkinson's Disease in Female Patients with Breast Cancer in Asian People: A Nationwide Population-Based Study.Tamoxifen usage correlates with increased risk of Parkinson's disease in older women with breast cancer: a case-control study in Taiwan.Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.Computational modeling of extracellular dopamine kinetics suggests low probability of neurotransmitter release.Sex differences in K+-evoked striatal dopamine output from superfused striatal tissue fragments of reserpine-treated CD-1 mice.Gender differences in Parkinson's disease
P2860
Q27349876-4A4C811C-0EEC-489D-8425-6FEDEF75526DQ33552831-C12B1DEF-3320-4F51-A37C-270715D175D1Q33604213-08E37EF8-3972-4D79-8634-1FE5159F447DQ33756791-116BFF65-23BF-49E9-878E-D28FA29043B3Q33956901-2BCC3531-62B3-4A1B-B596-1E660C614218Q34523361-F5A4C001-4DFA-44D8-A286-60C2F58DE850Q35972056-D0273A3D-0AC5-40D4-8E22-BEF5DEA6557DQ36335715-11FBB912-63A1-4B0A-BAA2-EAFDDFBC9C96Q36491681-A47F53B4-0651-4505-947D-CD3F4AD6C50DQ36653965-067B91D2-A4A1-4046-8609-7A3EABE84819Q36854132-184CF35D-4129-4145-87EB-466EB41EF888Q37352039-D6FCE1AF-7672-49AF-BBEF-C18CCF9FF55FQ37407288-BA2A2786-8CFD-4EC9-9CB1-95812F3DABC5Q43666121-9529F635-0E31-43A9-98D9-B8CADB4509A6Q44981188-8C944A7E-0AB6-4B24-A55B-6A563659B7E4Q46895969-B9756122-83D6-4C55-9F0A-A304EB564CFFQ47159085-4D5ED48A-F22E-448C-8A80-BDF208B980FBQ47623516-415D67F3-698D-40C6-B84E-7719C3A3F1FFQ48439931-58B45C38-4ECC-4304-880C-C6C6B50C3393Q50870752-029F1994-D448-4072-B467-E10B41E91C0FQ51743205-FB0560EE-A841-40C0-92AD-53B933500824Q57779630-348AA8A6-4C19-454C-94C1-B5272440A2F6
P2860
Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@en
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@nl
type
label
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@en
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@nl
prefLabel
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@en
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@nl
P1433
P1476
Tamoxifen abolishes estrogen's ...... ostriatal dopaminergic system.
@en
P304
P356
10.1016/S0306-4522(01)00014-8
P407
P577
2001-01-01T00:00:00Z